TSXV:BTI.H - Post by User
Comment by
prophetoffactzon Mar 01, 2023 1:05pm
96 Views
Post# 35312900
RE:RE:RE:Sangamo
RE:RE:RE:Sangamo"Yes, Chiesi most certainly is patient and does have a long term view..."
That's exciting. A top 50 pharma company with a long-term view and strategic focus on Lysosomal Storage and Saltarelli is on Chiesi's xB3 Advisory Board with Mei Mei and Rathjen and Rathjen was upbeat about BTI's partnerships despite the absense of news. Just because there is no news don't mean there isn't alot going on, I believe she said. Saltarelli has stayed with BTI and he has choices. He is world class. The former Group Director of Shire was also very positive about the partnerships after the due diligence for the merger. The deal attracted Ladenberg and successful fund Armistice Capital. Can't wait to see BTI's Hunter data which was scheduled for Q2 and any potential information concerning the long-term strategy of Chiesi with xB3. Ideally we see a Saltarelli - a deal consistent with world class and long-term value.